Sign In
4 Sep 2014 07:00
Biofrontera AG
("Biofrontera" or the "Company")
Director Dealing
Biofrontera AG (AIM:B8F), the European biopharmaceutical company, announces that on 3 September 2014 Thomas Schaffer, the Chief Financial Officer of the Company, purchased 1,000 ordinary shares of no par value in the capital of the Company ("Ordinary Shares") at an average price of EUR 2.318. Subsequent to this transaction Mr Schaffer has a beneficial interest in 8,088 Ordinary Shares representing 0.04% of the issued ordinary share capital of the Company.
For further information, please contact:
Biofrontera AG
|
| ||
Prof. Hermann Lübbert, Chief Executive Officer Thomas Schaffer , Chief Financial Officer | Tel: + 49 (0) 214 - 87632 - 22
| ||
|
| ||
finnCap (Nomad and Broker) |
| ||
Geoff Nash / Christopher Raggett (Corporate Finance) | Tel: 020 7220 0500 | ||
Steven Norcross(Corporate Broking) |
| ||
|
| ||
Investor Relations |
| ||
Seton Services |
| ||
Toni Vallen | Tel: 020 7603 6797 | ||
|
| ||
Financial PR Gable Communications |
| ||
John Bick | Tel: 020 7193 7463 |
Follow the stocks
